The maker of one of the leading COVID-19 vaccines announced a memorandum of understanding with the government Tuesday morning to open its first factory outside the United States. CEO Stéphane Bancel said the facility doesn’t have a location yet but it should be operational by 2024. (The Logic)
Talking point: The mRNA technology is so new that hardly any facilities make pharmaceuticals using it. Industry Minister François-Philippe Champagne said Moderna will enhance Canada’s bioscience ecosystem with the factory, a research centre and promises to use Canadian inputs. Federal commitments to buy the factory’s products are the core of the deal, he said, but the financial terms are undisclosed. Bancel said Moderna is working on mRNA-based vaccines for numerous viruses and treatments for cancer that could be made here—adding that the company hopes to make an annual all-in-one shot against influenza and respiratory bug RSV, with a COVID-19 booster thrown in—and some of the factory’s capacity will be available to make vaccines on demand in an emergency.